Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

NCT01606878 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Children's Oncology Group

Collaborators